Sequential TKI treatment in patients with chronic phase chronic myeloid leukemia resistant to frontline nilotinib or dasatinib therapy. A real-life survey from the Italian Campus CML Network
Gugliotta G et al. Clin Lymphoma Myeloma Leuk
Link to full abstract